TERF1 and glioblastoma: Both genetic ablation and chemical inhibition of TRF1 telomeric localisation can block the growth of p53-null K-RasG12V-induced lung carcinomas and PDGFA/B-induced glioblastomas in a telomere-length independent manner, remarkably without affecting mouse survival or tissue function1–3.